MA53448A - Composés agonistes des récepteurs bêta des hormones thyroïdiennes - Google Patents
Composés agonistes des récepteurs bêta des hormones thyroïdiennesInfo
- Publication number
- MA53448A MA53448A MA053448A MA53448A MA53448A MA 53448 A MA53448 A MA 53448A MA 053448 A MA053448 A MA 053448A MA 53448 A MA53448 A MA 53448A MA 53448 A MA53448 A MA 53448A
- Authority
- MA
- Morocco
- Prior art keywords
- receptor agonist
- thyroid hormone
- beta receptor
- agonist compounds
- hormone beta
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862722312P | 2018-08-24 | 2018-08-24 | |
| US201962867117P | 2019-06-26 | 2019-06-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA53448A true MA53448A (fr) | 2022-04-20 |
Family
ID=69584321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA053448A MA53448A (fr) | 2018-08-24 | 2019-08-23 | Composés agonistes des récepteurs bêta des hormones thyroïdiennes |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10800767B2 (fr) |
| EP (1) | EP3840755A4 (fr) |
| JP (1) | JP2021535207A (fr) |
| CN (1) | CN112805005A (fr) |
| AU (1) | AU2019325656A1 (fr) |
| CA (1) | CA3110520A1 (fr) |
| MA (1) | MA53448A (fr) |
| WO (1) | WO2020041741A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020077123A1 (fr) | 2018-10-12 | 2020-04-16 | Terns, Inc. | Composés agonistes du récepteur bêta des hormones thyroïdiennes |
| CN111320609A (zh) | 2018-12-13 | 2020-06-23 | 拓臻股份有限公司 | 一种THRβ受体激动剂化合物及其制备方法和用途 |
| PE20220255A1 (es) | 2019-05-08 | 2022-02-16 | Aligos Therapeutics Inc | Moduladores de thr y metodos de uso de estos |
| CN111909137B (zh) * | 2019-05-10 | 2023-05-30 | 深圳微芯生物科技股份有限公司 | 一种哒嗪酮衍生物及其应用 |
| JP2022548250A (ja) * | 2019-09-12 | 2022-11-17 | ターンズ・ファーマシューティカルズ・インコーポレイテッド | 甲状腺ホルモン受容体ベータアゴニスト化合物 |
| AU2021377248A1 (en) | 2020-11-13 | 2023-06-22 | Inipharm, Inc. | Dichlorophenol hsd17b13 inhibitors and uses thereof |
| US20240059682A1 (en) * | 2021-03-03 | 2024-02-22 | Terns Pharmaceuticals, Inc. | Thyroid hormone receptor beta agonist compounds |
| JP2024511015A (ja) * | 2021-03-19 | 2024-03-12 | メッドシャイン ディスカバリー インコーポレイテッド | 二環式フェノール系化合物及びその使用 |
| WO2022194287A1 (fr) * | 2021-03-19 | 2022-09-22 | 南京明德新药研发有限公司 | Composé de pyridinone bicyclique et son utilisation |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2003064369A1 (ja) | 2002-01-30 | 2005-05-26 | キッセイ薬品工業株式会社 | 新規な甲状腺ホルモン受容体リガンド、それを含有する医薬組成物、およびそれらの用途 |
| US7572799B2 (en) * | 2003-11-24 | 2009-08-11 | Pfizer Inc | Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors |
| GB0327319D0 (en) * | 2003-11-24 | 2003-12-24 | Pfizer Ltd | Novel pharmaceuticals |
| PL1919878T3 (pl) | 2005-07-21 | 2011-03-31 | Hoffmann La Roche | Pochodne pirydazynonu jako agoniści receptora hormonu tarczycy |
| WO2008130637A1 (fr) * | 2007-04-18 | 2008-10-30 | New York University | Composés hydrazide en tant que modulateur des récepteurs d'hormone thyroïdienne et leurs utilisations |
| EP3725779A4 (fr) | 2018-01-23 | 2021-02-24 | Shenzhen TargetRx, Inc. | Composé de pyridazinone substitué |
| CN111801324B (zh) | 2018-06-12 | 2021-10-22 | 四川海思科制药有限公司 | 甲状腺激素受体激动剂及其用途 |
| JP2022504706A (ja) | 2018-10-12 | 2022-01-13 | インベンティスバイオ カンパニー リミテッド | 甲状腺ホルモン受容体作動薬 |
-
2019
- 2019-08-23 JP JP2021533405A patent/JP2021535207A/ja active Pending
- 2019-08-23 CA CA3110520A patent/CA3110520A1/fr active Pending
- 2019-08-23 US US16/549,979 patent/US10800767B2/en active Active
- 2019-08-23 AU AU2019325656A patent/AU2019325656A1/en active Pending
- 2019-08-23 CN CN201980066702.0A patent/CN112805005A/zh active Pending
- 2019-08-23 MA MA053448A patent/MA53448A/fr unknown
- 2019-08-23 WO PCT/US2019/047968 patent/WO2020041741A1/fr unknown
- 2019-08-23 EP EP19852050.4A patent/EP3840755A4/fr active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN112805005A (zh) | 2021-05-14 |
| TW202023560A (zh) | 2020-07-01 |
| JP2021535207A (ja) | 2021-12-16 |
| US20200062742A1 (en) | 2020-02-27 |
| EP3840755A1 (fr) | 2021-06-30 |
| WO2020041741A1 (fr) | 2020-02-27 |
| AU2019325656A1 (en) | 2021-03-11 |
| CA3110520A1 (fr) | 2020-02-27 |
| US10800767B2 (en) | 2020-10-13 |
| EP3840755A4 (fr) | 2022-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA53448A (fr) | Composés agonistes des récepteurs bêta des hormones thyroïdiennes | |
| MA53868A (fr) | Composés agonistes du récepteur bêta des hormones thyroïdiennes | |
| IL282076A (en) | Thyroid hormone receptor agonists | |
| ZA201804997B (en) | Triple glucagon/glp-1/gip receptor agonist | |
| EP4017875A4 (fr) | Composés agonistes du récepteur bêta de l'hormone thyroïdienne | |
| EP3807267A4 (fr) | Agonistes du récepteur de l'hormone thyroïdienne et utilisations associées | |
| MA53382A (fr) | Composés co-agonistes de gip/glp1 | |
| MA52642A (fr) | Composés ciblant des récepteurs hormonaux nucléaires anticancéreux | |
| DK3762380T3 (da) | Phenylpyrrolidinon-formylpeptid-2-receptoragonister | |
| IL279504A (en) | GIP/GLP1 agonist compounds | |
| MA52948A (fr) | Composés | |
| DK3820873T3 (da) | Selektive østrogenreceptornedbrydere | |
| EP4028008A4 (fr) | Composés agonistes du récepteur bêta de l'hormone thyroïdienne | |
| MA51669A (fr) | Composés | |
| IL266985A (en) | Agents as peptide agonists for glp1/glucagon/gip receptors | |
| EP4036090A4 (fr) | Composé chimique en tant qu'agoniste du récepteur bêta de l'hormone thyroïdienne et son utilisation | |
| MA53003A (fr) | Composés | |
| MA41492A (fr) | Composés présentant une activité d'antagonistes de récepteur muscarinique et d'agonistes de récepteur bêta 2 adrénergique | |
| DK3820874T3 (da) | Selektive estrogenreceptornedbrydere | |
| IL304460A (en) | Estrogen receptor modulating compounds | |
| IL280367A (en) | CD226 agonist antibodies | |
| MA52946A (fr) | Composés | |
| GB201811757D0 (en) | Composition comprising GLP-1 receptor agonist and glucagon receptor agonist and application thereof | |
| GB201816639D0 (en) | GLP-1 Receptor Antagonist | |
| IL277243A (en) | Inverted pyrazoles are FFA4/GPR120 receptor agonists |